Work

Turning precision medicine into reality with statistics and data-driven decision making across pharmaceutical development

Year: 2026

Type: article

Abstract: Ten years after the launch of the Precision Medicine Initiative, its broader impact remains uncertain beyond select genetic and oncological cases. Here, we share our perspective as pharmaceutical statisticians and propose strategic shifts to realize its full potential. Desachy et al. share their perspectives as pharmaceutical statisticians on precision medicine. They find its broader impact uncertain despite select successes, and propose strategic shifts to realize its full potential.

Source: Communications Medicine

DOI: 10.1038/s43856-026-01524-7

Authors: Guillaume Desachy, Karl Köchert, Nicole Krämer, René Kubiak, Biomarkers European Special Interest Group

Institutions: Pierre Fabre (France), Sanofi (Germany), Boehringer Ingelheim (Germany)

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,690